1. Home
  2. VELO vs SCLX Comparison

VELO vs SCLX Comparison

Compare VELO & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Velo3D Inc.

VELO

Velo3D Inc.

N/A

Current Price

$11.06

Market Cap

102.9M

Sector

Technology

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$8.26

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VELO
SCLX
Founded
2014
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.9M
90.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VELO
SCLX
Price
$11.06
$8.26
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$18.00
N/A
AVG Volume (30 Days)
2.5M
74.7K
Earning Date
03-16-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,158,000.00
$40,360,000.00
Revenue This Year
$11.94
N/A
Revenue Next Year
$56.44
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
59.44
N/A
52 Week Low
$1.43
$3.60
52 Week High
$23.84
$34.27

Technical Indicators

Market Signals
Indicator
VELO
SCLX
Relative Strength Index (RSI) 42.00 33.19
Support Level $11.12 $8.12
Resistance Level $15.89 $9.50
Average True Range (ATR) 2.32 0.97
MACD -0.50 0.13
Stochastic Oscillator 1.52 14.98

Price Performance

Historical Comparison
VELO
SCLX

About VELO Velo3D Inc.

Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: